Upstream gene structure and mRNA expression of the human histamine H1 receptor gene was investigated in cells relevant to the pathogenesis of asthma, (primary cultured human airway smooth muscle cells, primary cultured bronchial epithelial cells and BEAS2B cells), and other tissues known to express histamine H1 receptors (placenta and brain). Splice variation of the 5' terminal exons gave three separate locations for novel promoters upstream of the detected transcription start sites. Further splice variants in the 5' untranslated region were also observed.
Rapid amplification of cDNA ends (RACE) RACE was performed using the GeneRacer kit (Invitrogen) with Superscript II, following the manufacturer's protocol, using 2.5µg RNA per reaction. For 5' RACE, primers to the HRH1 coding region were H1RACE1, CACCGAGGTCTGCTGCATGAAGTGATT, and H1RACENEST, GCGGTAGCGATCAATGCACAGGATGAA.
Primers to the β 2 Adrenergic receptor, used as a positive control, were β 2 RACE1, CAGGCTCTGGTACTTGAAAGGTGAA and β 2 RACE1NESTED, TGGCCGTGACGCACAGCACATCAAT.
Primers used for HRH1 3' RACE were 3RACECS1, TCACCATCTGGCTGGGCTACATCAA, and 3RACECS2, CTTGTGCAATGAAACTTCAAGAAGA.
For exon-specific RACE, primers GAAGCAGCTCACTCCTCAGTCTGTTA, and GTTCTCATCCTCTTACCCTGGCAAGA were used. 5' RACE products were not gel-isolated to allow detection of the widest range of transcripts and to avoid skewing the products obtained by size selection on a purification column.
Plasmid DNA obtained from RACE PCR clones was prepared using the Qiagen DNA miniprep kit and directly sequenced with vector primers M13F and M13R using an Applied Biosystems model ABI Prism 337 DNA sequencer or a model 3100 Genetic Analyser. Sequence data was analysed using the BLAST 2 sequence alignment program: www.ncbi.nlm.nih.gov/BLAST.
Generation of promoter/luciferase reporter constructs
Regions of the HRH1 gene containing 1002 or 2160 bp of promoter sequence plus 5' untranslated region (5'UTR)
were cloned into the luciferase reporter vector pGL3 Enhancer (Promega, Southampton, UK) as follows. In all cases, unless stated, Invitrogen Platinum Taq High Fidelity DNA polymerase was used. PCR conditions were as recommended by the manufacturer. All fragments were gel-isolated and purified using the StrataPrep DNA Gel Extraction Kit (Stratagene, Amsterdam, Netherlands). All construct inserts were sequenced as above.
For the promoter upstream of exon B, forward primers TTGTTGCTCGAGCTTAGGTGGTCCCTT and TTGTTGCTCGAGCTGCTTACCAGGGGCTTGAAAT were used with reverse primer, GTTGTTGTTCAAGCGCGCTCTTCTCAA, on a genomic DNA template derived from HASM cells to create 1kb
and 2kb fragments respectively. The forward primers had a 5' non-binding extension of TGG TGG CTCGAG which created the restriction site Xho1 in subsequent rounds of PCR amplification. The PCRx enhancer kit (Invitrogen) at 3X strength was found to be optimal for amplification of the promoter B PCR product. The part of the construct containing the 5'UTR was created by PCR with primers CGCCCAATACGCAAACCGCCT and TGGGGAGGCCCATGGGCGAAAGA on a RACE-derived clone using Biotaq (Bioline, London, UK). This clone contained the B 5' exon, transcription start site (TSS) and exon K to the HRH1 start ATG. The first PCR fragments (containing the promoter regions) were cut with Xho1 and an internal BstX1 site and the second fragments with the same internal BstX1 site and a created Nco1 site. Fragments were ligated into pGL3Enhancer which had been cut Xho1/Nco1. The completed construct therefore contained promoter sequence spliced to the 5'UTR region upstream of the luciferase coding region.
Similarly, for promoter A, (the region directly upstream of exon A), forward primers TTGTTGCTCGAGGGGAGAAAGAAGGAGAGG, TTGTTGCTCGAGTGCACCTCAGTGACCCT, and reverse primer GTTGTTCCAATCAGCCACCTCAG, were designed to amplify the same promoter lengths. Xho1 sites were included on the forward primers and the products cut with Xho1 and an internal Alw44I site. For the 1kb and 2kb products the PCRx enhancer kit at 2X strength and the Expand High Fidelity PCR system (Roche, Lewes, UK)
were used respectively. The 5'UTR was amplified from another RACE clone containing the A exon, TSS, exon K and HRH1 start site, using the same primers and polymerase as before, the fragment cut Alw44I /Nco1 and ligated as before.
For promoter F constructs, forward primers TGGTGGCTCGAGAGTGCTGGGAAGTGCCAC, TGGTGGCTCGAGAATCCTTGCCCTGAAGACTG, and reverse primer GTTGTTATAAGCAAACAGGTCTACTCC were used to generate 1kb and 2kb fragments from the region upstream of exon F, which were cut Xho1/Xma1. A RACE clone containing the F 5' exon, TSS, exon K and HRH1 start site was used as a template with the same primers and Taq polymerase as before to amplify a fragment which was cut Xma1/Nco1 and ligated as before.
Three constructs based on the previously published gene structure and containing the previously published promoters were made. Construct Hs contained upstream sequence, including exons I and H, of length 1002bp plus exon K to the HRH1 start ATG. Construct H1k and construct H2k contained 1002bp or 2160bp of sequence 5' to exon H respectively and included exons I, H plus exon K to the HRH1 start ATG. A previously prepared construct (pH1ENLWT) was used as template for PCR to prepare constructs Hs and H1k with forward primers, TGGTGGCTCGAGCTTTCTTCTGTTAGCAAAGT, and TGGTGGCTCGAGCATCTGTAGTTCGGATTAAATC, and reverse primer TGGGGAGGCCCATGGGCGAAAGA. Products were cut Xho1/Xmn1. Construct H2k was prepared by PCR on HASM genomic DNA with primers TGGTGGCTCGAGGATCTCCAGGCTGGTGTTG and CTGTAATTGAAGGTCTTCTCCA and the PCR product was cut Xho1/Xmn1. The 5'UTR portion of the constructs was subcloned from a previously prepared construct (pH1EN#8) by cutting Xmn1/Nco1, to give a fragment containing the HRH1 start site plus preceding exons H and I. The fragments were then ligated into pGL3Enhancer as before.
For sORF analysis a construct containing 392 bp (1639 to1994 and 7780 to 7817) of AJ000742 cloned upstream of the luciferase coding region in pGL3E was used. This region comprised exons H, I and K to the HRH1 start ATG, with some 5' sequence as shown by DeBacker et al. (15) . The Quickchange Site-directed mutagenesis kit (Stratagene) was used to change each upstream sORF ATG to CTG.
Transfection of promoter/reporter constructs
Transfections were carried out in 48 well tissue culture plates (Corning, Sunderland, UK) using Fugene (Roche) at a 3:1 Fugene:DNA ratio using 0.12µg DNA/well for the smallest plasmid (pGL3Enhancer) and scaling additions of DNA for the other plasmids according to size so an equimolar amount of each was used. Transfected cells were harvested after 48 hrs by lysing in Passive lysis buffer (Promega) using 65µl/well for HASM and 200µl/well for BEAS2B. Cells were rocked in lysis buffer for 15 minutes then subjected to a freeze/thaw at -80°C to ensure complete lysis. Supernatant (20µl) was assayed for luciferase activity using the Promega luciferase assay kit in a
Turner model 20e luminometer. Results from triplicate wells were averaged and the results expressed as fold activity in Turner Light Units (TLU) over the empty vector luciferase expression. Each experiment was performed three times in four plates and the results expressed as average fold activity + SEM.
Quantification of HRH1 transcript expression by TaqMan real-time PCR
Primer/probe sets were designed using Primer Express software version 1.5 (ABI). All probes were MGB with FAM reporter dye. The ABI PDAR primer/probe set (with VIC reporter dye), designed to detect the human 18s ribosomal subunit, was used as a control to correct for cDNA concentration. All probes and reagents were from ABI, except primers which were from Invitrogen. Assays were designed and validated according to ABI User Bulletin 2 with primers either side of a splice site and probes spanning the splice junction to increase specificity for cDNA ( except for the CDS where no splice junction was available 
Statistical Analysis
Statistical comparisons were made using either student t tests or analysis of variance (ANOVA) as appropriate.
Polymorphism screening
The three putative promoter regions and 5' terminal exons identified by RACE were amplified by PCR over the first 2100bp and the products directly sequenced from genomic DNA obtained from a departmental DNA archive, using the amplimers and overlapping internal primers to obtain sequence over the whole region. This process was also used to look for single nucleotide polymorphisms (SNPs) within the coding region and the first part of the region previously published as the HRH1 gene promoter (15) . Full ethical approval was obtained for all genotyping/sequencing studies. SNPs were identified by examining sequence chromatograms and BLAST analysis.
For 20 individuals complete information was obtained across all regions studied.
Results

Identification of HRH1 splice variants and promoter regions by 5' RACE
Initial RACE experiments were designed to define HRH1 transcripts. Results showed three common splice variants, A/K, B/K and F/K, with alternate 5' terminal exons. Exon sequences obtained by RACE were compared with AC083855, a GenBank clone containing the whole of the region, using BLAST 2 sequence analysis to obtain intronic distances. Fig. 1 shows schematic diagrams of genomic structure of the HRH1 gene (with the position of all exons detected shown) and splice variants detected by RACE. The most prevalent splice variant was B/K, accounting for 85% of clones sequenced in HASM, 36% in BEAS2B and 95% in brain (Table 1 ). This splice variant consisted of 5' terminal exon B, with multiple transcription start sites being identified spread over a 51 base region from 52704
to 52754, spliced to exon K, the 3' terminal exon, which comprised 5'UTR, coding region (CDS) and 3' untranslated region (3'UTR), with a splice site at -35bp relative to the HRH1 ATG start codon. Two further relatively common transcripts were observed: splice variant A/K comprised 5' terminal exon A spliced to exon K. This variant was seen in both BEAS2B and HASM, accounting for 5% and 9% of clones sequenced respectively (Table 1) . Splice variant F/K comprised 5' terminal exon F spliced to exon K. This variant was seen only in BEAS2B by standard RACE, accounting for 54% of clones obtained (Table 1) . By using a reverse primer specific to the 3' end of exon F, clones containing this exon were also obtained from HASM suggesting that some low level expression of this transcript does occur in this cell type, a result which was later confirmed by TaqMan analysis (see below). 5' terminal exon D was seen only once, derived from brain cDNA. Additional splice variants for the HRH1 gene were seen: a total of 11 splice variants incorporating additional exons, but all with exon B as the most 5' exon, were detected -two from BEAS2B and nine from HASM (Table 1) . Also, one splice variant with 5' terminal exon A and incorporating exon I was obtained from HASM. This variant has been assumed to splice to exon K since it was detected using a primer specific to exon I which bound 5' to the splice site at -35. These less common splice variants are also shown in Fig From 207 cDNA RACE clones analyzed by direct sequencing (Table 1) , data showed that the B 5' terminal exon was present in more clones than any other variant, suggesting that the region upstream of this exon is the dominant promoter in HASM cells and brain. However, in BEAS2B cells exon F was more common, contrasting with negligible expression of this exon in HASM or brain. Exon A was seen by RACE in a total of fifteen clones and was not detected in brain cDNA by this method.
The TSS positions observed demonstrated extensive minor variation for all variants. For example, the TSSs for exon B fell into three main clusters with exon lengths of 62, 27 and 24 bp respectively: these together accounting for 85% of the clones seen. The TSSs for exons A and F spread over a region of 280 bp and 299 base pairs respectively (Table 2 ). To ensure this was not an artefact of the RACE methods used, in parallel experiments RACE clones were also obtained for the human β 2 AR gene from HASM and BEAS2B cDNA to compare with published data for this gene which gave TSSs over a 20 bp region (1369-1391 of gi 178203) (19, 20) . Of 57 clones sequenced 75% showed TSSs at position 1382, whilst the other sites detected were spread over bases 1351-1385 overlapping with the published sites and extending 18 bp 5' to the most 5' previously published site at 1369.
It was noted that the thirteen most 5' bases of the previously described HRH1 clone AJ000742 were artefacts of library cloning. PCR with primers designed 5' and 3' to the published sequence as shown by GenBank produced bands, and subsequent direct sequencing confirmed these artefactual bases were not present, with the GenBank sequence continuing into the published sequence.
In order to eliminate the possibility that some of the clones observed originated from unprocessed transcripts, RACE was repeated on cytoplasmic RNA from one HASM donor: the same splice variants were detected. Sequences around each intron/exon boundary conformed extremely closely to consensus splice sequences, i.e. AG GTRAGT for the donor sequence and YnNYAG G for the acceptor sequence (21) even for rarer transcripts, giving high confidence that these represent real gene structures. In keeping with this observation, when splice variation was seen, the splice positions were still conserved.
Characterization of the 3' UTR of the HRH1
Four bands of DNA were obtained from a nested PCR 3' RACE reaction using HASM cDNA and these were individually gel purified, cloned and sequenced. Of these, three seemed to be priming from 'A' rich sequence areas, so further gel purification was performed to isolate DNA larger than 2kb. The longest clone detected from the repurified reaction was 2752bp long, suggesting use of the polyadenlation motif (AATAAA) starting at 161444 in AC083855. Other long clones of 2304, 2305 and 2312 bp were obtained and showed a polyadenylation motif starting at 160995 (see Table 2 ). No 3' A rich regions were present in genomic DNA downstream of either of these 3' clone ends. We believe therefore that these probably represent true 3' ends of the gene, however further polyadenlyation motifs do exist at 161739, 161929 and 161931 which, if used, would give rise to longer 3'UTRs.
Transient Transfection of promoter/reporter constructs
Reporter constructs based on pGL3Enhancer and containing 1 and 2kb regions of DNA upstream of, and including, Table 3 ). All positions are numbered relative to AC083855. Five novel SNPs were seen in promoter A and we confirmed the presence of two SNPs already present in the NCBI SNP database. Promoter B showed only one novel SNP and promoter F showed three novel and two database SNPs. The portion of sequence spliced out in the cells studied here, but previously described as the HRH1 promoter, showed seven SNPs, three novel and four previously described in the database and elsewhere (23). Sequencing of the coding region of the gene confirmed the presence of two previously described SNPs (24). One SNP, previously described by Sasaki et al. (25) was seen in the 5'UTR of exon K at -17 relative to the ATG start codon.
Species sequence comparison
Exon B is a highly conserved region which is present upstream of the mouse H1R gene with the same splice sites conserved, (the mouse has an additional exon between this exon and the 3' terminal exon comprising positions 65 to 211 of NM_008285). This conserved region is also present in contig NW_047696.1 genomic DNA which BLASTS to rat chromosome 4, a region containing the rat H1R gene homologue. The region is also highly conserved in porcine cDNA (BP154008.1) where it splices to an equivalent of the human exon K containing a porcine H1R coding region homologue with 88 % amino acid identity to the human receptor over the 231 amino acids available for comparison. The B exon also has high homology to a region of canine genomic DNA (NW 139888) found on the same chromosome (twenty) as the canine H1R homologue and is a total match for sequence from chimp genomic DNA on NW104865, which BLASTs to the same chromosome (three) area as the chimp H1R gene (see Fig. 4 ).
Discussion
In this paper we have for the first time provided a comprehensive characterization of the structure of the human H1
receptor gene and provided a description of the transcripts observed in a range of cell types. We demonstrate that tissue specific expression of transcripts occurs in physiologically relevant cell types. This is likely to be driven by the selective usage of the three main HRH1 promoters identified in different cell types. In particular, airway epithelial cells (including the BEAS2B cell line, and both differentiated and undifferentiated HBEC cultures) have increased expression of transcript variant F/K, which is expressed at barely detectable levels in airway smooth muscle, and HBEC cells also have high expression of variant A/K. Evidence for this differential expression profile of HRH1 transcripts comes both from extensive RACE experiments, and from quantitative PCR experiments. In the latter work, we were also able to estimate the probable contribution of the identified transcripts to the total coding region transcripts by comparing the abundance of the different 5' UTR transcripts with total HRH1 coding region mRNA: these experiments suggest that in each cell type studied we were able to account for over 65% of all transcripts present, indicating that although some rarer transcripts may not have been identified, the majority of transcript species contributing to expression of the HRH1 were found. The final piece of evidence supporting the identity of the novel exons we found is the high degree of evolutionary conservation present within these regions between species for exon B, which also extends to the main splice sites identified.
These data contrast with a previous study which describes an upstream gene structure of the HRH1 gene (15) . In this paper, a TSS was identified at the 5' end of exon H. We believe this probably represents a truncated splice variant, based upon our inability to identify this transcript except with additional 5' exons spliced to exons H and I (see Our findings that the HRH1 gene shows splice variation, and therefore has at least three putative promoter regions, may begin to explain some of the differences seen in the effects of cellular mediators on histamine H1 gene expression between cell types and species, although further studies will be needed to define the mechanisms underlying the effects of different mediators.
In the complexity of mRNA transcripts arising from this locus, the HRH1 gene is similar to other airway GPCRs, such as the muscarinic M2 receptor (CHRM2) (35), although other receptors with intronless coding regions do have simpler upstream structures. A good example of the latter is the human β2 adrenoceptor gene (ADRB2), which has an intronless 5' UTR with TSSs found within a 20bp region a short distance upstream of the coding region (19, 20) .
RACE data presented here for the ADRB2 gene supports this observation (no splice variation was observed) and also by inference provide further evidence that the HRH1 transcripts identified are not likely to be artefactual. Finally, to exclude the possibility that some HRH1 transcripts arose from unprocessed mRNA, we also examined RACE products derived from HASM cytoplasmic RNA which gave results comparable to those obtained with total RNA from cell lysates.
In addition to defining the main promoter regions used by the HRH1 in a range of relevant cell types, we have undertaken a polymorphism search of the coding region, the region containing the previously studied promoter, and the novel promoters we identified. The whole genomic region is relatively rich in polymorphisms, and a number of novel SNPs were identified: some previously identified SNPs were also found In summary, the upstream gene structure of the HRH1 gene is considerably more complex than previously believed, with three main promoters being present. The mechanisms underlying tissue specific expression of different transcripts require further study. The evidence provided here for active, cell type specific, regulation of transcript species suggests an important physiological role for transcriptional regulation at this locus in governing response to stimuli which release histamine in the airways and other tissues. Chimp genomic DNA sequence shows a 100% match to human exon B in NW_104865 from chromosome 3, the same chromosome location as the chimp H1R homologue.
Tables
Canine genomic DNA sequence from contig NW_139888 shows a highly conserved region which BLASTS to same chromosome location as the canine H1R homologue (chromosome 20).
Rat genomic sequence from chromosome 4 blasts to same contig NW_047696.1 as the rat H1R homologue.
Murine H1R mRNA sequence NM_008285 on chromosome 6 shows an exon B equivalent is separated from the CDS exon by another exon. Splice site positions are conserved.
Porcine cDNA exon B equivalent shows splice site conservation and splices to an exon K equivalent and H1R CDS homologue which shows 88% amino acid identity to the human H1 receptor CDS over the region available for comparison (BP154008.1). 
